Birchview Capital’s ContraFect Corporation CFRX Stock Holding History

Birchview Capital’s Portfolio CFRX Stock Details CFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,500	Closed	-$34K	–	63
2022 Q3	$34K	Hold	2,500	–	–	0.02%	58
2022 Q2	$614K	Hold	2,500	–	–	0.45%	33
2022 Q1	$730K	Hold	2,500	–	–	0.53%	33
2021 Q4	$526K	Hold	2,500	–	–	0.34%	43
2021 Q3	$810K	Hold	2,500	–	–	0.55%	33
2021 Q2	$880K	Hold	2,500	–	–	0.53%	35
2021 Q1	$960K	Hold	2,500	–	–	0.57%	32
2020 Q4	$1.01M	Sell	2,500 -696	-22%	-$301K	0.58%	29
2020 Q3	$1.35M	Hold	3,196	–	–	0.9%	20
2020 Q2	$1.63M	Hold	3,196	–	–	0.99%	18
2020 Q1	$1.47M	Sell	3,196 -338	-10%	-$231K	1.31%	14
2019 Q4	$1.75M	Buy	3,534 +3,250	+1,144%	+$942K	1.28%	8
2019 Q3	$81K	Sell	284 -16	-5%	-$5.38K	0.05%	46
2019 Q2	$123K	Hold	300	–	–	0.07%	46
2019 Q1	$96K	Hold	300	–	–	0.06%	50
2018 Q4	$368K	Sell	300 -696	-70%	-$1.1M	0.35%	31
2018 Q3	$1.65M	Sell	996 -348	-26%	-$576K	1.07%	8
2018 Q2	$2.38M	Sell	1,344 -75	-5%	-$110K	1.61%	4
2018 Q1	$1.84M	Hold	1,419	–	–	1.22%	7
2017 Q4	$1.15M	Hold	1,419	–	–	0.67%	12
2017 Q3	$1.26M	Buy	1,419 +513	+57%	+$485K	0.65%	11
2017 Q2	$1.05M	Hold	906	–	–	0.56%	12
2017 Q1	$1.3M	Hold	906	–	–	0.73%	9
2016 Q4	$1.27M	Hold	906	–	–	0.78%	9
2016 Q3	$1.8M	Buy	906 +312	+53%	+$613K	1.05%	7
2016 Q2	$1.37M	Hold	594	–	–	1%	9
2016 Q1	$1.61M	Hold	594	–	–	1.15%	7
2015 Q4	$2.26M	Buy	594 +25	+4%	+$83.5K	1.3%	5
2015 Q3	$2.02M	Hold	569	–	–	1.3%	6
2015 Q2	$2.15M	Buy	+569	New	+$2.31M	1.14%	10

Other funds holding CFRX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Birchview Capital's CFRX Position: Q4 2022 in Review

Birchview Capital sold out of ContraFect Corporation (CFRX) in Q4 2022, closing a stake of 2,500 shares — an estimated $34K sold.

Birchview Capital first reported a position in CFRX in Q2 2015 and held it in 30 quarters. The position peaked at $2.38M in Q2 2018. 40 funds tracked by Wall St. Rank hold CFRX as of Q4 2022.

Birchview Capital reported no remaining ContraFect Corporation position as of Q4 2022 after selling out during the quarter.
Birchview Capital sold 2,500 ContraFect Corporation shares in Q4 2022, an estimated $34K.
Birchview Capital first reported a position in ContraFect Corporation in Q2 2015 and held it in 30 quarters.
Birchview Capital's ContraFect Corporation position peaked at $2.38M in Q2 2018.
40 funds tracked by Wall St. Rank held ContraFect Corporation as of Q4 2022.

Based on Birchview Capital's 13F filing for Q4 2022, filed 3 Feb 2023.